ArticleFrontiers in endocrinology2025
Association between triglyceride-glucose index and major adverse cardiovascular events in patients with intermediate coronary stenosis: a prospective cohort study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- TyG index predicts adverse cardiovascular outcomes in patients with multimorbidity of hypertension and obstructive coronary artery disease: a cohort study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the correlation between the triglyceride-glucose (TyG) index and the incidence of major adverse cardiovascular events (MACE) in patients with intermediate coronary stenosis. Methods and results: A prospective cohort study was conducted involving 217 patients diagnosed with intermediate coronary stenosis confirmed by coronary angiography at Kaifeng Central Hospital. Patients were stratified into quartiles based on the TyG index and were followed for a median period of 858 days. During the follow-up, 35 patients experienced MACE. Kaplan-Meier survival analysis, adjusted for confounding variables in Model 3, demonstrated a significantly elevated risk of MACE in the highest TyG quartile compared with those in the lowest quartile (log-rank Conclusion: The TyG index was independently correlated with an increased incidence of MACE in patients with intermediate coronary stenosis. Subgroup analyses indicated that this correlation was particularly pronounced in patients with diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.